跳至主要内容
临床试验/NCT05022745
NCT05022745Unknown4 期

ERAS Protocol for Single-level Posterior Lumbar Arthrodesis; a Randomized Prospective Study

AZ Nikolaas2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2021年7月8日最近更新:
适应症

试验速览

阶段
4 期
发起方
AZ Nikolaas
入组人数
110
试验地点
2
主要终点
Length of hospital stay

研究概览

简要总结

Enhanced Recovery After Surgery (ERAS) is a multidisciplinary, multimodal approach aiming to improve surgical outcomes. This study compares the length of hospital stay of patients undergoing single-level posterior lumbar arthrodesis and treated with the ERAS protocol with the hospital stay of patients treated according to the standard protocol.

详细描述

Hundred and ten patients scheduled for single-level posterior lumbar arthrodesis (PLIA) will be randomized to be treated by the standard protocol or the Enhanced Recovery After Surgery (ERAS) protocol. The ERAS protocol differs from the standard protocol in 4 phases: pre-operative counseling and intake, day of surgery, the pre-operative patient preparation, the per-operatively used analgesic and anesthetic drug combination, and the post-operative care consisting of a more intensive physical therapy in the ERAS group. It is the objective the mobilize patients more rapidly without compromising the comfort in terms of pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

The interventions described in the patient information brochure make masking impossible

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for a single level PLIA as treatment of mono segmental degenerative instability, as seen on dynamic X-rays, after the failure of 6 months conservative therapy Capable of understanding the provided information Giving informed consent

排除标准

  • Revision surgery Arthrodesis for trauma, neoplasms, infection, or listhesis due to lysis. High dose opioid use (step 3 of the WHO pain ladder) Diabetes Cognitive impairment (baseline dementia, cognitive dysfunction, or inability to consent to participate).
  • Known kidney insufficiency: GFR <30 mL/min/1.73 m2 Allergy/intolerance/contraindication to any medication or component included in the ERAS pathway protocol Patients with a risk factor for reflux

结局指标

主要结局

Length of hospital stay

时间窗: 2-3 days + 11 days

Number of days hospitalization

次要结局

  • Pain intensity(day of discharge)
  • 11-days readmission rate(discharge + 11 days)
  • Analgesic use, including opioids(2-3)

研究者

发起方
AZ Nikolaas
申办方类型
Other
责任方
Principal Investigator
主要研究者

Erik Van de Kelft, M.D., PhD

Head of neurosurgery department

AZ Nikolaas

研究点 (2)

Loading locations...

相似试验

ERAS Protocol for Single-level Posterior Lumbar... | 临床试验